4
Changes in Ownership
INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-23-000004
Director sold 11,668 shares at $1.28 ($14,935)
- Director acquired 23,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Weiner David B. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-26 | Exercise or conversion : show line 1 in the form | +11,667 | 904,292 | D | ||
| 2023-02-26 | Exercise or conversion : show line 2 in the form | +11,667 | 915,959 | D | ||
| 2023-02-27 | Sale : show line 3 in the form | −11,668 | $1.28 | $14,935 | 904,291 | D |
| Open-market sales · 11,668 sh · avg $1.28 · $14,935 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-26 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −11,667 | 11,666 | D |
| 2023-02-26 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −11,667 | 23,333 | D |
| 2023-02-27 | Grant or award : show line 6 in the form Common Stock Option | +60,000 | 60,000 | D |
| 2023-02-27 | Grant or award : show line 7 in the form Restricted Stock Unit | +35,000 | 35,000 | D |
Loading xslF345X03/wf-form4_167762396172703.xml…